Suchergebnisse - "Helms, Julie"

PubPharm (26)

1

TLRs1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections

enthalten in: Journal of innate immunity | 2024

von Chomel, L. | Vogt, M. | Demiselle, J. | +8

2

Disseminated intravascular coagulation is strongly associated with severe acute kidney injury in patients with septic shock

enthalten in: Annals of intensive care | 2023

von Helms, J. | Merdji, H. | Loewert, S. | +6

3

Disseminated intravascular coagulation is strongly associated with severe acute kidney injury in patients with septic shock

enthalten in: Annals of intensive care | 2023

von Helms, J. | Merdji, H. | Loewert, S. | +6

4

Sex and gender differences in intensive care medicine

enthalten in: Intensive care medicine | 2023

von Merdji, H. | Long, M. | Ostermann, M. | +9

5

Staphylococcus epidermidis bloodstream infections are a cause of septic shock in intensive care unit patients

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Demiselle, J. | Meyer, P. | Lavigne, T. | +13

6

Sex and gender differences in intensive care medicine

enthalten in: Intensive care medicine | 2023

von Merdji, H. | Long, M. | Ostermann, M. | +9

7

Differential effect on mortality of the timing of initiation of renal replacement therapy according to the criteria used to diagnose acute kidney injury : an IDEAL-ICU substudy

enthalten in: Critical care (London, England) | 2023

von Barbar, S. | Bourredjem, A. | Trusson, R. | +35

8

Septic shock as a trigger of arterial stress-induced premature senescence : A new pathway involved in the post sepsis long-term cardiovascular complications

enthalten in: Vascular pharmacology | 2021

von Merdji, H. | Kassem, M. | Chomel, L. | +8

9

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients : the AdrenOSS-2 phase 2a biomarker-guided trial

enthalten in: Intensive care medicine | 2021

von Laterre, P. | Pickkers, P. | Marx, G. | +77

10

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

enthalten in: Intensive care medicine | 2021

von Laterre, P. | Pickkers, P. | Marx, G. | +24